Abstract:Familial Hypophosphatasia presents a complex diagnostic challenge due to its wide-ranging clinical manifestations and genetic heterogeneity. This study aims to elucidate the molecular underpinnings of familial Hypophosphatasia within a Tunisian family harboring a rare c.896 T > C mutation in the ALPL gene, offering insights into genotype–phenotype correlations and potential therapeutic avenues. The study employs a comprehensive approach, integrating biochemical examination, genetic analysis, structural modeling, and functional insights to unravel the impact of this rare mutation. Genetic investigation revealed the presence of the p.Leu299Pro mutation within the ALPL gene in affected family members. This mutation is strategically positioned in proximity to both the catalytic site and the metal-binding domain, suggesting potential functional consequences. Homology modeling techniques were employed to predict the 3D structure of TNSALP, providing insights into the structural context of the mutation. Our findings suggest that the mutation may induce conformational changes in the vicinity of the catalytic site and metal-binding domain, potentially affecting substrate recognition and catalytic efficiency. Molecular dynamics simulations were instrumental in elucidating the dynamic behavior of the tissue-nonspecific alkaline phosphatase isozyme (TNSALP) in the presence of the p.Leu299Pro mutation. The simulations indicated alterations in structural flexibility near the mutation site, with potential ramifications for the enzyme's overall stability and function. These dynamic changes may influence the catalytic efficiency of TNSALP, shedding light on the molecular underpinnings of the observed clinical manifestations within the Tunisian family. The clinical presentation of affected individuals highlighted significant phenotypic heterogeneity, underscoring the complex genotype–phenotype correlations in familial Hypophosphatasia. Variability in age of onset, severity of symptoms, and radiographic features was observed, emphasizing the need for a nuanced understanding of the clinical spectrum associated with the p.Leu299Pro mutation. This study advances our understanding of familial Hypophosphatasia by delineating the molecular consequences of the p.Leu299Pro mutation in the ALPL gene. By integrating genetic, structural, and clinical analyses, we provide insights into disease pathogenesis and lay the groundwork for personalized therapeutic strategies tailored to specific genetic profiles. Our findings underscore the importance of comprehensive genetic and clinical evaluation in guiding precision medicine approaches for familial Hypophosphatasia.

Effect of oral iron chelation therapy with deferiprone (L1) on the psychosocial status of thalassaemia patients.

One Patient with Perinatal Hypophosphatasia Due to Mutations in the Tissue-Nonspecific Alkaline Phosphatase Gene

Six ALPL gene variants in five children with hypophosphatasia

Systemic effects of hypophosphatasia characterization of two novel variants in the ALPL gene

Functional Evaluation of Mutations in the Tissue-Nonspecific Alkaline Phosphatase Gene.

A Novel Missense Mutation in the Alpl Gene Causes Dysfunction of the Protein

Characterization of Genetic Variants of Uncertain Significance for the ALPL Gene in Patients With Adult Hypophosphatasia

Case Report: Variations in the ALPL Gene in Chinese Patients With Hypophosphatasia

Characteristics of the Syrian Hamster Ribonucleic Acid Present in Cells Transformed by Polyoma, Simian Virus 40, or Adenovirus 12

Lethal Perinatal Hypophosphatasia Caused by a Novel Compound Heterozygous Mutation: a Case Report

Neuromuscular features of hypophosphatasia

Periodontal Defects in the A116T Knock-in Murine Model of Odontohypophosphatasia

The structural pathology for hypophosphatasia caused by malfunctional tissue non-specific alkaline phosphatase

Alkaline Phosphatase Controls Lineage Switching of Mesenchymal Stem Cells by Regulating the LRP6/GSK3β Complex in Hypophosphatasia.

Hypophosphatasia: Vitamin B6 status of affected children and adults

Ionomycin Ameliorates Hypophosphatasia Via Rescuing Alkaline Phosphatase Deficiency-Mediated L-type Ca2+ Channel Internalization in Mesenchymal Stem Cells

Catalyzing precision: unraveling the diagnostic conundrum of tunisian familial hypophosphatasia case through integrative clinical and molecular approaches

A Novel Case of Concomitant PHEX and ALPL Mutation In a Family With Rickets

A case report of odonto-hypophosphatasia with a novel variant in the ALPL gene

Tissue nonspecific alkaline phosphatase deficiency impairs Purkinje cell development and survival in a mouse model of infantile hypophosphatasia

New insights into the landscape of ALPL gene variants in patients with hypophosphatasia from the Global HPP Registry